
Supreme Court Seems Skeptical of Bid to Restrict Abortion Pill Access
The Supreme Court appeared skeptical of a challenge brought by a doctors’ group against the Food and Drug Administration’s (FDA) loosening of regulations of the abortion pill mifepristone. In oral arguments on March 26, several justices seemed to question whether the doctors’ group had a right to bring the challenge, known in legal parlance as standing—a key argument in the government’s case. The court heard oral arguments in two consolidated cases—Food and Drug Administration (FDA) v. Alliance for Hippocratic Medicine (AHM) and Danco Laboratories LLC v. AHM. The AHM is represented by the Alliance for Defending Freedom (ADF). AHM’s website states that the consortium of medical organizations “upholds and promotes the fundamental principles of Hippocratic medicine.”...
